Analyze Diet

Topic:Pharmacodynamics

Pharmacodynamics in horses refers to the study of how drugs affect the equine body, encompassing the mechanisms of action, the relationship between drug concentration and effect, and the duration of these effects. This field examines how drugs interact with biological systems in horses to produce therapeutic or adverse effects. Key aspects include receptor binding, post-receptor effects, and chemical interactions. Understanding pharmacodynamics is essential for determining appropriate dosages, predicting drug interactions, and assessing therapeutic outcomes in equine medicine. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacodynamic properties of various drugs in horses, focusing on their effects, efficacy, and safety profiles.
[Use of local anaesthetics in the horse. Pharmacological and legal aspects].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 6, 2011   Volume 39, Issue 2 117-123 
Kästner S.No abstract available
Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Journal of veterinary pharmacology and therapeutics    December 2, 2011   Volume 35, Issue 4 413-416 doi: 10.1111/j.1365-2885.2011.01356.x
Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG.No abstract available
Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses.
Veterinary anaesthesia and analgesia    November 22, 2011   Volume 39, Issue 1 1-11 doi: 10.1111/j.1467-2995.2011.00653.x
Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.To elaborate constant rate infusion (CRI) protocols for xylazine (X) and xylazine/butorphanol (XB) which will result in constant sedation and steady xylazine plasma concentrations. Methods: Blinded randomized experimental study. Methods: Ten adult research horses. Methods: Part I: After normal height of head above ground (HHAG = 100%) was determined, a loading dose of xylazine (1 mg kg(-1) ) with butorphanol (XB: 18 μg kg(-1) ) or saline (X: equal volume) was given slowly intravenously (IV). Immediately afterwards, a CRI of butorphanol (XB: 25 μg kg(-1) hour(-1)) or saline (X) was administer...
Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse.
Veterinary anaesthesia and analgesia    November 22, 2011   Volume 39, Issue 1 38-48 doi: 10.1111/j.1467-2995.2011.00669.x
Grimsrud KN, Mama KR, Steffey EP, Stanley SD.To describe the pharmacodynamics and pharmacokinetics following an intravenous (IV) bolus dose of medetomidine in the horse. Methods: Prospective experimental trial. Methods: Eight, mature healthy horses age 11.7 ± 4.6 (mean ± SD) years, weighing 557 ± 54 kg. Methods: Medetomidine (10 μg kg(-1) ) was administered IV. Blood was sampled at fixed time points from before drug administration to 48 hours post administration. Behavioral, physiological and biochemical data were obtained at predetermined time points from 0 minutes to 24 hours post administration. An algometer was also used to measu...
Pharmacokinetic assessment of ketanserin in the horse.
Journal of veterinary pharmacology and therapeutics    November 18, 2011   Volume 35, Issue 5 472-477 doi: 10.1111/j.1365-2885.2011.01346.x
Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD.The purpose of this study was to determine the pharmacokinetics (PK) of the 5-HT(2A) receptor antagonist ketanserin in healthy adult horses, and to develop a computational model that could be used to optimize dosing. Plasma concentrations of ketanserin were determined using liquid chromatography with mass spectrometry after single and multiple intravenous administration in the horse. A two-compartment linear pharmacokinetic model described the plasma concentration-time profile of ketanserin after single and multiple doses in healthy horses; the terminal half-life was 11.5 h; steady-state volum...
Relationship between dose of cloprostenol and age of corpus luteum on the luteolytic response of early dioestrous mares: a field study.
Reproduction in domestic animals = Zuchthygiene    November 4, 2011   Volume 47, Issue 4 660-665 doi: 10.1111/j.1439-0531.2011.01940.x
Cuervo-Arango J, Newcombe JR.The objective of this study was to establish and characterize the relationship between the dose of cloprostenol (37.5, 250, 500 and 750 μg) and the age of the early corpus luteum (CL) (80, 88, 96, 104 and 112 h) on the luteolytic response of mares. Behavioural oestrus and ultrasonographic signs of return to oestrus were considered as the occurrence of full luteolysis. A total of 298 mares were divided into groups according to dose of cloprostenol and CL age. There was an effect of dose of cloprostenol (p < 0.001) and age of the CL at the time of treatment (p 0.05); and that of 500 similar...
In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.
Schweizer Archiv fur Tierheilkunde    November 3, 2011   Volume 153, Issue 11 509-513 doi: 10.1024/0036-7281/a000262
Müller JM, Wissemann J, Meli ML, Dasen G, Lutz H, Heinzerling L, Feige K.Whole blood pharmacokinetics of intratumourally injected naked plasmid DNA coding for equine Interleukin 12 (IL-12) was assessed as a means of in vivo gene transfer in the treatment of melanoma in grey horses. The expression of induced interferon gamma (IFN-g) was evaluated in order to determine the pharmacodynamic properties of in vivo gene transduction. Seven grey horses bearing melanoma were injected intratumourally with 250 µg naked plasmid DNA coding for IL-12. Peripheral blood and biopsies from the injection site were taken at 13 time points until day 14 post injection (p.i.). Samples w...
Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
American journal of veterinary research    October 4, 2011   Volume 72, Issue 10 1378-1385 doi: 10.2460/ajvr.72.10.1378
Dimaio Knych HK, Stanley SD.To characterize pharmacokinetics and pharmacodynamics of detomidine gel administered sublingually in accordance with label instructions to establish appropriate withdrawal guidelines for horses before competition. Methods: 12 adult racehorses. Methods: Horses received a single sublingual administration of 0.04 mg of detomidine/kg. Blood samples were collected before and up to 72 hours after drug administration. Urine samples were collected for 5 days after detomidine administration. Plasma and urine samples were analyzed via liquid chromatography-mass spectrometry, and resulting data were anal...
Early use of Xeomin neurotoxin for local anti-spasticity therapy for pes equines after acquired brain injury (ABI).
Brain injury    September 30, 2011   Volume 25, Issue 12 1266-1269 doi: 10.3109/02699052.2011.613085
Lippert-Gruner M, Svestkova O.The acute management of spasticity following ABI is challenging. Contractures can occur during the acute phases of illness. The joints most affected are the shoulders and the ankles. Methods: A case study of a 48-year-old female patient who received local chemoneurolytic anti-spasticity therapy following a severe subarachnoid haemorrhage for pes equines deformity is presented to illustrate the role of focal neurotoxin therapy. Methods: The increasing spasticity in her legs was observed and could not be effectively treated with oral anti-spasticity agents or intensive physiotherapy. As spastici...
Reevaluation of the effect of phenylephrine on resolution of nephrosplenic entrapment by the rolling procedure in 87 horses.
Veterinary surgery : VS    September 20, 2011   Volume 40, Issue 7 825-829 doi: 10.1111/j.1532-950X.2011.00879.x
Baker WT, Frederick J, Giguere S, Lynch TM, Lehmkuhl HD, Slone DE.To evaluate the outcome in horses treated with a rolling technique or surgically for nephrosplenic entrapment of the large colon (NSE) and to examine the benefit of phenylephrine (PE) HCl on the efficacy of nonsurgical (rolling) management of NSE. Methods: Case series. Methods: Horses (n = 211) diagnosed with NSE by rectal palpation with or without ultrasonography, or at the time of exploratory celiotomy or necropsy. Methods: Medical records (January 1, 2001-September 1, 2008) were collected from horses diagnosed with NSE at 2 referral centers. Records were used to obtain signalment, physical ...
Effect of experimentally induced synovitis on amikacin concentrations after intravenous regional limb perfusion.
Veterinary surgery : VS    September 8, 2011   Volume 40, Issue 7 891-897 doi: 10.1111/j.1532-950X.2011.00875.x
Beccar-Varela AM, Epstein KL, White CL.To determine the effects of experimentally induced synovitis of the radiocarpal joint on the intra-articular pharmacokinetics and pharmacodynamics of amikacin after intravenous regional limb perfusion (IVRLP). Methods: Randomized crossover experimental design. Methods: Adult horses (n = 8). Methods: Horses were randomly assigned into 2 trials: synovitis and no-synovitis. Radiocarpal joint synovitis was induced with lipopolysaccharide 6 hours before IVRLP. IVRLP (5-mg/kg amikacin qs 60 mL) was performed with a pneumatic tourniquet under general anesthesia. Synovial fluid was obtained before and...
The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse.
Veterinary anaesthesia and analgesia    August 13, 2011   Volume 38, Issue 5 431-438 doi: 10.1111/j.1467-2995.2011.00634.x
Goodwin WA, Keates HL, Pasloske K, Pearson M, Sauer B, Ranasinghe MG.To determine the pharmacokinetics and pharmacodynamics of the neurosteroidal anaesthetic, alfaxalone, in horses after a single intravenous (IV) injection of alfaxalone, following premedication with acepromazine, xylazine and guaiphenesin. Methods: Prospective experimental study. Methods: Ten (five male and five female), adult, healthy, Standardbred horses. Methods: Horses were premedicated with acepromazine (0.03 mg kg(-1) IV). Twenty minutes later they received xylazine (1 mg kg(-1) IV), then after 5 minutes, guaiphenesin (35 mg kg(-1) IV) followed immediately by IV induction of anaesthesia w...
The effect of nonsteroidal anti-inflammatory drugs on the equine intestine.
Equine veterinary journal. Supplement    August 4, 2011   Issue 39 140-144 doi: 10.1111/j.2042-3306.2011.00398.x
Marshall JF, Blikslager AT.Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in the management of pain and endotoxaemia associated with colic in the horse. While NSAIDs effectively treat the symptoms of colic, there is evidence to suggest that their administration is associated with adverse gastrointestinal effects including right dorsal colitis and inhibition of mucosal barrier healing. Several studies have examined the pathophysiology of NSAID associated effects on the large and small intestine in an effort to avoid these complications and identify effective alternative medications. Differences in the re...
Cardiovascular effects of N-butylscopolammonium bromide and xylazine in horses.
Equine veterinary journal. Supplement    August 4, 2011   Issue 39 117-122 doi: 10.1111/j.2042-3306.2011.00400.x
Morton AJ, Varney CR, Ekiri AB, Grosche A.N-butylscopolammonium bromide (NBB) and xylazine are commonly used medications for the treatment of spasmodic colic and other forms of abdominal pain in horses. Both NBB and xylazine exert significant effects on the cardiovascular system and other vital systems of horses. Objective: To evaluate the effects of i.v. administration of NBB, xylazine, and the combination of NBB and xylazine on heart rate, other commonly measured physiological parameters, cardiac rhythm and blood pressure. Methods: Six mature horses of mixed breed were used. In a random cross-over design, each horse was given 0.3 mg...
A targeted lipidomics approach to the study of eicosanoid release in synovial joints.
Arthritis research & therapy    July 27, 2011   Volume 13, Issue 4 R123 doi: 10.1186/ar3427
de Grauw JC, van de Lest CH, van Weeren PR.Articular tissues are capable of producing a range of eicosanoid mediators, each of which has individual biological effects and may be affected by anti-inflammatory treatment. We set out to develop and evaluate a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) approach for the simultaneous analysis of multiple eicosanoid lipid mediators in equine synovial fluid (SF), and to illustrate its use for investigation of the in vivo effects of non-steroidal anti-inflammatory drug (NSAID) treatment. Methods: Synovial fluid samples were obtained from normal joints of 6 adult...
Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals.
Drug metabolism and disposition: the biological fate of chemicals    June 20, 2011   Volume 39, Issue 9 1643-1649 doi: 10.1124/dmd.111.039206
Peters J, Block W, Oswald S, Freyer J, Grube M, Kroemer HK, Lämmer M, Lütjohann D, Venner M, Siegmund W.The delivery of clarithromycin (CRL) to its site of action in bronchial/alveolar epithelial cells (EC), bronchial epithelial lining fluid (ELF), and bronchoalveolar lavage cells (BALC) may be influenced by CYP3A4 and the drug transporters, ATP-binding cassette (ABC) B1 and ABCC2 and organic anion-transporting polypeptides (OATPs), which can be modulated and/or up-regulated via the nuclear pregnane X receptor (PXR) by rifampicin (RIF). Therefore, we evaluated the disposition and pulmonary distribution of CLR (7.5 mg/kg b.i.d., 21 days) and expression of ABCB1, ABCC2, OATP1A2, and OATP2B1 in EC ...
Evaluation of sedation and analgesia in standing horses after administration of xylazine, butorphanol, and subanesthetic doses of ketamine.
Journal of the American Veterinary Medical Association    June 16, 2011   Volume 238, Issue 12 1629-1633 doi: 10.2460/javma.238.12.1629
Wagner AE, Mama KR, Contino EK, Ferris DJ, Kawcak CE.To evaluate the sedative and analgesic effects of subanesthetic doses of ketamine in horses sedated with xylazine, with or without butorphanol. Methods: Prospective, randomized, controlled study. Methods: 10 adult horses. Methods: Each horse was sedated multiple times by administration of xylazine (treatment X), xylazine and butorphanol (treatment XB), xylazine with 1 of 2 dosages of ketamine (treatment XK1 or XK2), or xylazine and butorphanol with 1 of 2 dosages of ketamine (treatment XBK1 or XBK2). Head height and various behaviors, including responses to noise, insertion of a dental float, ...
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Haematologica    May 23, 2011   Volume 96, Issue 9 1269-1275 doi: 10.3324/haematol.2011.042622
Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP.A combination of horse anti-thymocyte globulin and cyclosporine produces responses in 60-70% of patients with severe aplastic anemia. We performed a phase II study of rabbit anti-thymocyte globulin and cyclosporine as first-line therapy for severe aplastic anemia. Methods: Twenty patients with severe aplastic anemia treated with rabbit anti-thymocyte globulin were compared to 67 historical control cases with matched clinical characteristics treated with horse anti-thymocyte globulin. Results: Response rates at 3, 6 and 12 months were similar for patients treated with rabbit anti-thymocyte glob...
In vitro and ex vivo pharmacodynamics of selected non-steroidal anti-inflammatory drugs in equine whole blood.
Veterinary journal (London, England : 1997)    May 11, 2011   Volume 191, Issue 3 327-333 doi: 10.1016/j.tvjl.2011.03.016
Cuniberti B, Odore R, Barbero R, Cagnardi P, Badino P, Girardi C, Re G.Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenases (COX), and the inhibition of COX-2 rather than COX-1 can limit the onset of NSAID-related adverse effects. The pharmacodynamic properties of eltenac, naproxen, tepoxalin, SC-560 and NS 398 in healthy horses were investigated using an in vitro whole blood assay. To predict COX selectivity in clinical use, eltenac and naproxen were also studied ex vivo after intravenous administration. SC-560 acted as a selective COX-1 inhibitor, tepoxalin as a dual inhibitor with potent activity against COX-1, and NS 398 as a preferential CO...
The effect of systemic administration of cloprostenol on ovulation in mares treated with a prostaglandin synthetase inhibitor.
Reproduction in domestic animals = Zuchthygiene    April 20, 2011   Volume 47, Issue 1 32-38 doi: 10.1111/j.1439-0531.2011.01796.x
Cuervo-Arango J.Prostaglandins (PGs) are essential to trigger the cascade of events that degrade the extracellular matrix of follicles leading to follicular rupture and ovulation. In mares, systemic administration of flunixin meglumine (FM), a PG synthetase inhibitor, blocks ovulation by inducing luteinized unruptured follicles (LUF). In the rat, the administration of PGF(2α) (PGF) and PGE restored ovulation in indomethacin treated animals. The mares were treated with FM 0, 12, 24 and 36 h after human chorionic gonadotrophin (hCG) administration to induce experimentally LUF (n = 15) or were left untreated (c...
Effect of Buscopan compositum on the motility of the duodenum, cecum and left ventral colon in healthy conscious horses.
Berliner und Munchener tierarztliche Wochenschrift    April 6, 2011   Volume 124, Issue 3-4 168-174 
Gomaa N, Uhlig A, Schusser GF.Seven adult, healthy, conscious warmblood horses were used in a crossover study. They were fed twice a day on 1 kg hay/100 kg BW and 0.5 kg concentrates with unlimited access to water. One hour after feeding, the contractive motility of the descending duodenum, cecal body and left ventral colon were measured using a 5 MHz transcutaneus ultrasonographic transducer. Each horse was treated with 0.9% NaCl (5 ml/100 kg BW; i.v.), and with Buscopan compositum (BC) at its therapeutic dosage (25 mg/kg BW; metamizol-sodium, 0.2 mg/kg BW; N-butylscopolammonium bromide, i.v.) in a control and an experime...
Characterization of in vivo plasma metabolites of tepoxalin in horses using LC-MS-MS.
Journal of pharmaceutical and biomedical analysis    March 30, 2011   Volume 56, Issue 1 45-53 doi: 10.1016/j.jpba.2011.03.028
Giorgi M, Mengozzi G, Raffaelli A, Saba A.Tepoxalin is a veterinary drug registered for use in the dog as a dual inhibitor (cyclooxygenase-5 lipoxygenase). In the horse, it predominantly triggers a strong cyclooxygenase inhibition; this bias seems to be due to the action of its metabolite(s). Among these, only the RWJ-20142 is well known, while to the best of our knowledge no information is available on the other metabolites produced in vivo. Hence, the identification of its main metabolic pathway is pivotal to better understand its clinical activity. A suitable high performance liquid chromatography method has been applied to liquid ...
Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals.
Journal of veterinary pharmacology and therapeutics    March 28, 2011   Volume 35, Issue 1 59-66 doi: 10.1111/j.1365-2885.2011.01292.x
Berghaus LJ, Giguère S, Sturgill TL, Bade D, Malinski TJ, Huang R.The objectives of this study were to determine the plasma and pulmonary disposition of gamithromycin in foals and to investigate the in vitro activity of the drug against Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Rhodococcus equi. A single dose of gamithromycin (6 mg/kg of body weight) was administered intramuscularly. Concentrations of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and blood neutrophils were determined using HPLC with tandem mass spectrometry detection. The minimum inhibitory concentration of gamithr...
Intra-articular injection of morphine to the horse: establishment of an in vitro-in vivo relationship.
Drug development and industrial pharmacy    March 21, 2011   Volume 37, Issue 9 1043-1048 doi: 10.3109/03639045.2011.559245
Frost AB, Lindegaard C, Larsen F, Østergaard J, Larsen SW, Larsen C.In the area of parenteral depots, a strong need exists for the development of suitable in vitro drug release models that might enable establishment of in vitro-in vivo relations (IVIVRs). Objective: The objective of this study was to investigate the possibility of establishing an IVIVR between morphine disappearance from the joint cavity and in vitro release data obtained employing the rotating dialysis cell model. Methods: In vitro release experiments were conducted using the rotating dialysis cell model. For establishment of an IVIVR, data from a previous study on pharmacokinetics of intra-a...
Effects of two methods of administration on the pharmacokinetics of ceftiofur crystalline free acid in horses.
Journal of veterinary pharmacology and therapeutics    March 15, 2011   Volume 34, Issue 2 193-196 doi: 10.1111/j.1365-2885.2010.01224.x
Giguère S, Sturgill TL, Berghaus LJ, Grover GS, Brown SA.No abstract available
Analysis of gabapentin in equine plasma with measurement uncertainty estimation by liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology    March 15, 2011   Volume 35, Issue 2 75-84 doi: 10.1093/anatox/35.2.75
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Rudy JA, Chen JW.Gabapentin (GPT) is an antiepileptic drug that was approved in 1993 for use in the management of neurotrophic pain and as an adjunctive therapy for refractory partial seizure in humans. It is also being tested in veterinary medicine as an adjunctive medication in the treatment of pain due to laminitis, neuropathic, or chronic pain. Gabapentin is readily available by prescription and even on the internet; therefore, it has the potential of being used in racehorses to mask pain. It is for this reason that a sensitive liquid chromatography-tandem mass spectrometry method has now been developed fo...
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction.
Equine veterinary journal    March 11, 2011   Volume 43, Issue 4 393-398 doi: 10.1111/j.2042-3306.2010.00313.x
Bertin FR, Ivester KM, Couëtil LL.Studies investigating the clinical efficacy of albuterol administered with the same propellant and commercially available delivery devices in horses with recurrent airway obstruction (RAO) are not currently available. Objective: To determine the efficacy of aerosolised albuterol administered to horses with RAO by means of 2 commercially available, hand-held delivery devices. Methods: Ten horses with RAO were kept in a dusty environment and fed mouldy hay to induce airway obstruction. Lung mechanics were measured before and after the procedure. ΔP(max) was measured 5 min after administration o...
Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.
Journal of veterinary pharmacology and therapeutics    March 2, 2011   Volume 34, Issue 6 605-608 doi: 10.1111/j.1365-2885.2011.01272.x
Rumpler MJ, Sams RA, Colahan P.No abstract available
Modulating effects of acepromazine on the reactive oxygen species production by stimulated equine neutrophils.
Veterinary anaesthesia and analgesia    February 10, 2011   Volume 38, Issue 2 83-93 doi: 10.1111/j.1467-2995.2010.00583.x
Sandersen C, Mouithys-Mickalad A, de la Rebière G, Deby G, Serteyn D, Franck T.To investigate the effect of acepromazine (ACP) on reactive oxygen species (ROS) production by stimulated equine neutrophils. Methods: Ex vivo biochemical experiments. Methods: Isolated neutrophils from healthy untreated horses. Methods: Neutrophils were incubated with ACP at concentrations of 10(-4), 10(-5) or 10(-6) M and then stimulated with phorbol-myristate-acetate (PMA) before measurement of lucigenin-enhanced chemiluminescence (CL). In a second experiment neutrophils were incubated in the presence of α-keto-γ methylthiobutyric acid (KMB) and treated with ACP at concentrations of 10(-4...
Analysis of bioactive eicosanoids in equine plasma by stable isotope dilution reversed-phase liquid chromatography/multiple reaction monitoring mass spectrometry.
Rapid communications in mass spectrometry : RCM    February 4, 2011   Volume 25, Issue 5 585-598 doi: 10.1002/rcm.4893
Mangal D, Uboh CE, Soma LR.Oxidative metabolites of arachidonic acid (AA) are implicated in inflammation. Thus, we evaluated cycloxygenases (COXs) and lipoxygenases (LOs) mediated metabolism of AA to eicosanoids in equine plasma. Eicosanoids were extracted from plasma by two liquid-liquid extraction (LLE) steps; first was by chloroform/isopropanol and second by methyl-tert-butyl ether. For identification and quantification of 25 eicosanoids, a highly specific, selective and sensitive stable isotope dilution liquid chromatography (LC) multiple reaction monitoring (MRM) mass spectrometric (MS) method was developed. To avo...
1 … 13 14 15 16 17 … 41